Resmed SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

10-QOct. 29, 2026, 6:11 p.m. ETView on SEC.gov
8-KOct. 29, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Other events · Financial statements and exhibits
AI summary, unreviewedResMed Q1 fiscal 2027 non-GAAP EPS $2.91 beats $2.67 consensus on $1.415 billion revenue; full-year guidance reiterated
4Oct. 26, 2026, 3:39 p.m. ETView on SEC.gov
4Oct. 8, 2026, 5:31 p.m. ETView on SEC.gov
4/AOct. 1, 2026, 4:29 p.m. ETView on SEC.gov
4Oct. 1, 2026, 4:27 p.m. ETView on SEC.gov
4Oct. 1, 2026, 4:23 p.m. ETView on SEC.gov
4Oct. 1, 2026, 4:19 p.m. ETView on SEC.gov
4Oct. 1, 2026, 4:08 p.m. ETView on SEC.gov
4Sept. 10, 2026, 6:40 a.m. ETView on SEC.gov
4Sept. 4, 2026, 6:30 a.m. ETView on SEC.gov
8-KSept. 1, 2026, 4:30 p.m. ETView on SEC.gov
Other events
8-KAug. 17, 2026, 4:30 p.m. ETView on SEC.gov
Change in certifying accountant · Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
10-KAug. 13, 2026, 5:17 p.m. ETView on SEC.gov
4Aug. 11, 2026, 6:30 a.m. ETView on SEC.gov
SCHEDULE 13GAug. 7, 2026, 3:47 p.m. ETView on SEC.gov
8-KAug. 6, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Other events · Financial statements and exhibits
4Aug. 6, 2026, 2:29 p.m. ETView on SEC.gov